Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniel de Klerk
Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance
Cancers
Cancer Research
Oncology
Related publications
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer
Cancer Research
Cancer Research
Oncology
Tumor Exome Sequencing and Copy Number Alterations Reveal Potential Predictors of Intrinsic Resistance to Multi-Targeted Tyrosine Kinase Inhibitors
Oncotarget
Oncology
Development of Covalent Inhibitors That Can Overcome Resistance to First-Generation FGFR Kinase Inhibitors
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The Use of Nanoparticle-Mediated Targeted Gene Silencing and Drug Delivery to Overcome Tumor Drug Resistance
Biomaterials
Mechanics of Materials
Biophysics
Biomaterials
Bioengineering
Composites
Nanoscience
Nanotechnology
Ceramics
A Dynamic N6-Methyladenosine Methylome Regulates Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors
Cell Research
Cell Biology
Molecular Biology
Resistance to ErbB2 Tyrosine Kinase Inhibitors in Breast Cancer Is Mediated by Calcium-Dependent Activation of RelA
Molecular Cancer Therapeutics
Cancer Research
Oncology
Targeting Efflux Pumps to Overcome Antifungal Drug Resistance
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
Combination of Crizotinib and Osimertinib or Erlotinib Might Overcome MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutated Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics